MedCity News

OCTOBER 12, 2022

This dearth of maternity care providers is exacerbating the country’s less-than-stellar reputation for birth outcomes. In order to ensure better health for mothers and their newborns, OB-GYNs must identify risk factors that negatively impact pregnancy early on and work to maintain the whole picture of their pregnant patients’ health. However, OB-GYNs aren’t incentivized to do this under a fee-for-service payment model.

Patients 117

Patients 117

PharmaVoice

OCTOBER 12, 2022

As the Healthcare Businesswomen’s Association’s first chief people and DEI officer, Jones is poised to tackle pay gap inequity, systemic gender bias and leadership barriers impeding women of color.

Healthcare 105

Healthcare Healthcare 105

MedCity News

OCTOBER 12, 2022

Too many of us and our families have been affected by dementia in one form or another. October is recognized by patients, advocates and the medical community as Lewy Body Dementia Awareness month, and perhaps this year it will mark new hope for those suffering from this disease.

Medical 109

Medical Patients Biopharma 109

pharmaphorum

OCTOBER 12, 2022

It’s no secret that the healthcare system is made up of a panoply of diverse stakeholders, each with their own priorities, incentives, and motivations. Bringing those stakeholders together is an oft-lauded goal, but it’s proved easier said than done. The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine.

Medicine 101

Medicine Training Education Healthcare 101

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

OCTOBER 12, 2022

Moderna and Merck have been partners in the development of messenger RNA cancer vaccines since 2016. Merck is deepening the alliance by exercising an option that enables it to share equally in further work on a partnered cancer vaccine for melanoma.

Biopharma 106

Biopharma Pharma 106

Celeritas

OCTOBER 12, 2022

Over the last decade, the US BioTech and Pharma industries have truly flourished, with pharma-related discoveries and innovations growing at an increasing rate. In line with this trend, there is building pressure on HCPs to adopt newer processes and prescribe advanced medication. Due to rigid FDA regulations, however, pharma financial resources are often depleted in generating drugs which fail to pass the approval process.

Pharma 98

Pharma Marketing Sales Sales presentations 98

pharmaphorum

OCTOBER 12, 2022

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has exercised an option in its collaboration with the mRNA vaccine specialist, first agreed in 2016 and expanded two years later to include additional candidates.

Patients 90

Patients Manufacturing Sales Management 90

MedCity News

OCTOBER 12, 2022

The years ahead will require the ongoing enactment of meaningful policy, ongoing research and investment, and foresighted dedication to innovative solutions and technical advancements that support patient engagement and activation.

Patients 105

Patients 105

pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes.

Medicine 88

Medicine Patients Healthcare Healthcare 88

MedCity News

OCTOBER 12, 2022

CMS is proposing a system in which it would collect information from providers that would go in a single national directory it maintains. AHIP is seeking a more collaborative directory between the government and private insurers.

Insurance 102

Insurance Government 102

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

European Pharmaceutical Review

OCTOBER 12, 2022

A Phase III trial evaluating TauRx Therapeutics’ oral drug hydromethylthionine mesylate (HMTM), a tau aggression inhibitor, showed the medication continued to improve cognition over a pre-treatment baseline in patients with early Alzheimer’s for the first time. It has potential to become the first DMT targeting tau to be approved for the condition, stated Pippa Salter, Senior Neurology Analyst at GlobalData.

Side effects 88

Side effects Safety Patients Sales 88

MedCity News

OCTOBER 12, 2022

If telehealth flexibilities are not protected once the public health emergency expires, many Americans will lose their access to virtual care. To prevent this, the healthcare industry must advocate for the extension of these benefits for at least two years following the end of the emergency, with guardrails placed around two key areas — the prescription of addictive medications and audio-only visits.

Prescription 100

Prescription Healthcare Healthcare Medical 100

PharmaVoice

OCTOBER 12, 2022

The “magic bullet” approach of ADCs has been a breakthrough in cancer care — but this excitement could be just the beginning.

98

98

MedCity News

OCTOBER 12, 2022

The strike authorization vote comes after survey results earlier this month that showed 68 percent of respondents reported they are contemplating leaving public employment with the county in the next three years.

Physicians 101

Physicians 101

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

pharmaphorum

OCTOBER 12, 2022

Remaining compliant is imperative to the life sciences industry, so adhering to regulatory requirements is mandatory. Prior to selling drugs or medical products in any country, pharmaceutical companies must prove compliance and gain the regulatory approval required by the country in which the goods will be distributed in. By remaining compliant, medicines are manufactured in line with their pre-defined and approved specifications, in order to ensure the delivery of safe and effective products to

Manufacturing 86

Manufacturing Medicine Leads Distribution 86

MedCity News

OCTOBER 12, 2022

The funding round was led by Town Hall Ventures. Brave Health is primarily focused on providing mental health services for those on Medicaid, a rarity for mental health providers.

96

96

pharmaphorum

OCTOBER 12, 2022

Aptar Pharma has added another element to its suite of digital support tools for patients as they make their journey through the healthcare system. The new disease management platform will allow for better patient treatment adherence tracking, according to the company, which says it will create an “end-to-end” digital health programme that will support patients “from the prevention and diagnosis phases, to disease management, and more, across multiple therapeutic areas.”

Management 83

Management Pharma Healthcare Provider Healthcare 83

MedCity News

OCTOBER 12, 2022

LGBTQ virtual care platform Folx Health recently closed a $30 million Series B financing round, bringing the startup’s total funding to date to roughly $60 million. The company will use the money to expand its services, including the addition of clinician-led support groups. The first of these support groups will focus on queer fertility and family planning.

89

89

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Pharmaceutical Commerce

OCTOBER 12, 2022

Partnership looks to provide supply chain support for products in this sector, ranging from early clinical phase to commercial scale.

92

92

MedCity News

OCTOBER 12, 2022

Ascidian Therapeutics is developing therapies for inherited disorders that work by editing RNA with an approach that could offer advantages over currently available genetic medicines. The biotech’s lead program is in preclinical development for Stargardt disease, a rare eye disorder caused by multiple genetic mutations.

Medicine 85

Medicine Leads Biopharma Pharma 85

Pharmaceutical Technology

OCTOBER 12, 2022

Novo Nordisk has recently completed its six-part ONWARDS Phase III trial, as ONWARDS 5 reached its primary endpoint with Icodec demonstrating non-inferiority in reducing hemoglobin A1C (HbA1c) in patients with type 2 diabetes (T2D) at week 52 in comparison to once-daily basal insulin analogs. This successful outcome for insulin icodec increases the likelihood of achieving Food and Drug Administration (FDA) approval next year, which will establish Novo Nordisk’s dominance in the basal insulin mar

Food and Drug Administration 72

Food and Drug Administration FDA Marketing Food 72

PharmaTimes

OCTOBER 12, 2022

DIT to showcase Liverpool city region’s life sciences expertise which will also include manufacturing

Government 95

Government Manufacturing 95

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

PharmaTech

OCTOBER 12, 2022

CBER maps modernization plan to handle surge in research and applications.

FDA 109

FDA 109

PharmaTimes

OCTOBER 12, 2022

Development will boost life sciences sector by delivering significant lab space in Cambridge

99

99

pharmaphorum

OCTOBER 12, 2022

AstraZeneca has teamed up with DNA sequencing giant Illumina on a new programme that will use artificial intelligence to find new targets for drug discovery by sifting through vast arrays of data generated from “omics” studies. Overall, the aim is to improve the efficiency of drug discovery by identifying genetic variants that contribute to human disease in omics data – a broad category that includes DNA profiles, gene transcripts, and protein expression.

Pharma 64

Pharma Training Networking Leads 64

Pharmaceutical Technology

OCTOBER 12, 2022

Neumora Therapeutics has raised $112m in a Series B financing round to advance its new precision medicine candidates pipeline for neuropsychiatric disorders and neurodegenerative diseases. New and existing investors including F-Prime Capital, Altitude Life Science Ventures, Mubadala Capital, Amgen, Exor Ventures, ARCH Venture Partners, Invus, Abu Dhabi Growth Fund (ADG), Newpath Partners, Polaris Partners, as well as other undisclosed investors have participated in the financing round.

Medicine 59

Medicine Leads Pharmaceutical 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

pharmaphorum

OCTOBER 12, 2022

Walmart is the latest US retail pharmacy giant to announce its intention of disrupting the clinical trials category, with the launch of a new institute that pledges to increase and diversify community access to healthcare research. The Walmart Healthcare Research Institute (WHRI) won’t be running trials itself, but will spearhead Walmart’s efforts to connect patients who visit its massive, nationwide chain of health centres with organisations running clinical trials.

Retail 64

Retail Recruitment Healthcare Healthcare 64

Impetus Digital

OCTOBER 12, 2022

Register for Impetus’ upcoming live webinar on October 26, 2 – 3 PM ET: A Fireside Chat with Brad Womble, Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare. About the webinar. Brad Womble , Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare , will sit down with Natalie Yeadon , Co-founder & CEO of Impetus Digital , in this live episode of Healthcare Goes Digital.

Healthcare 56

Healthcare Healthcare Marketing Professional Services 56

Pharma Pathway

OCTOBER 12, 2022

Mankind Pharma Limited- Openings for Engineering – Water System & Electrical Process Area – Sterile Injectable– Apply Now. Job Description. Openings for Engineering – Water System & Electrical Process Area – Sterile Injectable @ Mankind Pharma Limited. Engineering – Water System & Electrical Process Area – Sterile Injectable.

Engineering 58

Engineering Pharma 58

Pharmaceutical Technology

OCTOBER 12, 2022

Nimbus Therapeutics and Eli Lilly and Company (Lilly) have signed a research partnership and licence agreement to develop and market new therapies that activate a specific AMPK isoform to treat metabolic diseases. Under the collaboration deal, Nimbus will develop isoform-selective small molecule AMPK activators to potentially treat several metabolic diseases using its computational drug discovery engine and structure-based drug design knowledge.

Engineering 52

Engineering Marketing Sales Leads 52

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients